MAXYGEN INC
S-3/A, EX-23.2, 2001-01-19
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: MAXYGEN INC, S-3/A, EX-23.1, 2001-01-19
Next: MUNICIPAL INVEST TR FD INTERM TERM SER 402 DEF ASSET FDS, 497, 2001-01-19



<PAGE>

                                                                    Exhibit 23.2



                        CONSENT OF INDEPENDENT AUDITORS

We have issued our reports dated February 23, 2000 (except for Notes 11 and 12
as to which the date is October 23, 2000), accompanying the financial statements
of ProFound Pharma A/S appearing in the current report of Maxygen, Inc. on Form
8-K/A (File No. 000-28401 filed on October 24, 2000) which are incorporated by
reference in this Registration Statement. We consent to the incorporation by
reference in this Registration Statement of the aforementioned reports.

/s/ Grant Thornton Denmark Ltd.

Copenhagen, Denmark

January 19, 2001



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission